Business
The Starpharma (ASX:SPL) share price is 35% below its 52-week high
Shares in mid-cap ASX biopharmaceuticals company Starpharma Holdings Limited (ASX: SPL) have endured a volatile start to 2021. After surging to an all-time high of $2.52 by mid-February, the company’s shares have now plunged more than 35% to just $1.62 as at the time of writing.
While…
Continue Reading
-
Noosa News17 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News18 hours agoForum responds to urgent homelessness issues in Nambour
-
General17 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
General20 hours agoFirst home buyers score early access to deposit scheme